Companies / Santa Cruz Biotechnology / Cytokeratin 10/13 (DE-K13)
Santa Cruz Biotechnology

Cytokeratin 10/13 (DE-K13) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; Cytokeratins (also designated KRT10 antibody, Keratin 10 antibody, cytokeratin 10 antibody, KRT13 antibody, Keratin 13 antibody, or cytokeratin 13 antibody) comprise a diverse group of intermediate filament proteins (IFPs) that are expressed as pairs in both keratinized and non-keratinized epithelial tissue (1,2). Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells (3,4). Cytokeratins have been found to be useful markers of tissue differentiation which is directly applicable to the characterization of malignant tumors (5,6). For example, cytokeratins 10 and 13 are expressed highly in a subset of squamous cell carcinomas while cytokeratin 18 is expressed in a majority of adenocarcinomas and basal cell carcinomas (5-6).

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.